Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
122,470,452
-
Total 13F shares
-
22,392,855
-
Share change
-
+2,692,543
-
Total reported value
-
$274,091,081
-
Price per share
-
$12.24
-
Number of holders
-
61
-
Value change
-
+$31,576,470
-
Number of buys
-
39
-
Number of sells
-
32
Institutional Holders of Arcus Biosciences, Inc. - Common Stock (RCUS) as of Q2 2018
As of 30 Jun 2018,
Arcus Biosciences, Inc. - Common Stock (RCUS) was held by
61 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,392,855 shares.
The largest 10 holders included
Alphabet Inc., WELLINGTON MANAGEMENT GROUP LLP, Foresite Capital Management III, LLC, EcoR1 Capital, LLC, BVF INC/IL, Partner Fund Management, L.P., Hillhouse Capital Management, Ltd., PRICE T ROWE ASSOCIATES INC /MD/, Board of Trustees of The Leland Stanford Junior University, and JANUS HENDERSON GROUP PLC.
This page lists
61
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.